Daxor Corp has a market cap of $46.8 million; its shares were traded at around $11.03 with a P/E ratio of 8.1 and P/S ratio of 27.7. DXR is in the portfolios of Jim Simons of Renaissance Technologies LLC.
This is the annual revenues and earnings per share of DXR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of DXR.
Highlight of Business Operations:For the three months ended March 31, 2010, consolidated operating revenues decreased to $396,272 from $434,037 for the same period in 2009, a decrease of $37,765 or 8.70%. This was mainly due to a decrease in revenue from Blood volume kit sales of $36,844 or 11.90% from $309,452 to $272,608. The number of kits sold decreased by 11.12% from 971 to 863 during the current period.
At March 31, 2010, Daxor owned 932,700 shares of Dynegy with a cost basis of $2.33 per share and a market value of $1.26 per share. On May 10, 2010, the market price of Dynegy was $1.35 per share which is $0.98 or 42% lower than our cost basis of $2.33 per share.
The book value of Dynegy at March 31, 2010 is $5.13 per share which is more than double our cost basis of $2.33 per share. The stock price of Dynegy has a record of historical volatility, being at $8.11 per share in February 2008, as low as $1.05 in March 2009 before going back to $2.42 per share in October 2009.
Dynegy s liquidity improved from $1.9 billion at December 31, 2009 to $2.3 billion at March 31, 2010. The liquidity at March 31, 2010 consisted of $802 million in cash on hand and marketable securities and $1.5 billion in unused availability under the company s credit facility. Dynegy s current ratio improved from $140 million at December 31, 2009 to $1.06 billion at March 31, 2010.
At March 31, 2010, Daxor owned 299,807 shares of Citigroup with a cost basis of $6.14 per share and a market value of $4.05 per share. On May 10, 2010, the market value of Citigroup was $4.22 per share which is $1.92 or 31% less than our cost basis of $6.14 per share.
Gains on the sale of investments were $6,076,382 for the three months ended March 31, 2010 versus $5,124,034 for the same period in 2009 for an increase of $952,348 or 18.59%. For the current quarter, the Company had a loss from the marking to the market of short positions of stocks and put and call options of ($4,772,764) versus a loss of ($6,318,524) for the same period in 2009. Interest expense net of interest income was $6,264 for the three months ended March 31, 2010 versus $67,699 for the three months ended March 31, 2009. Administrative expenses relating to portfolio investments were $34,974 in 2010 versus $ 31,886 for the same period in 2009.
Read the The complete Report